Antimicrob Agents Chemother 2012, 56:5845–5851.PubMedCrossRef 18. Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K: Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus this website aureus from heterogeneous vancomycin-intermediate CP673451 in vitro resistance to vancomycin-intermediate resistance. Antimicrob Agents Chemother 2008, 52:45–53.PubMedCrossRef 19. Meehl M, Herbert S, Götz F, Cheung A: Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus . Antimicrob Agents Chemother 2007,
51:2679–2689.PubMedCrossRef 20. Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL: An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus . Antimicrob Agents Chemother 2010, 54:5222–5233.PubMedCrossRef 21. Watanabe Y, Cui L,
Katayama Y, Kozue K, Hiramatsu K: Impact of rpoB mutations on reduced vancomycin find more susceptibility in Staphylococcus aureus . J Clin Microbiol 2011, 49:2680–2684.PubMedCrossRef 22. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K: Mutation of RNA polymerase beta subunit ( rpoB ) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob Agents Chemother 2011, 55:4188–4195.PubMedCrossRef 23. Passalacqua KD, Satola SW, Crispell EK, Read TD: A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility Atezolizumab mouse to vancomycin and daptomycin. Antimicrob Agents Chemother 2012, 56:5212–5223.PubMedCrossRef 24. Jousselin A, Renzoni A, Andrey DO, Monod A, Lew DP, Kelley WL: The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus . Antimicrob Agents
Chemother 2012, 56:3629–3640.PubMedCrossRef 25. Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y: walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus . Antimicrob Agents Chemother 2011, 55:3870–3881.PubMedCrossRef 26. Maki H, McCallum N, Bischoff M, Wada A, Berger-Bächi B: tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus . Antimicrob Agents Chemother 2004, 48:1953–1959.PubMedCrossRef 27. Jansen A, Türck M, Szekat C, Nagel M, Clever I, Bierbaum G: Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus . Int J Med Microbiol 2007, 297:205–215.PubMedCrossRef 28. Wada A, Katayama Y, Hiramatsu K, Yokota T: Southern hybridization analysis of the mecA deletion from methicillin-resistant Staphylococcus aureus . Biochem Biophys Res Commun 1991, 176:1319–1325.PubMedCrossRef 29.